India Plasma Fractionation Market — Market Growth, Trends, Opportunities, and Forecast
The India Plasma Fractionation Market is expanding as demand increases for plasma-derived therapies used in the treatment of neurological, hematological, immunological, and other medical conditions. According to Market Research Future, the market was valued at USD 2,386.5 million in 2024 and is projected to reach USD 4,815.3 million by 2035, growing at a CAGR of 6.59% during 2025–2035.
Rising demand for immunoglobulins and coagulation factors is one of the major factors supporting market growth. The increasing prevalence of chronic, autoimmune, and blood-related disorders is encouraging healthcare providers to adopt plasma-derived products for specialized treatments. Expanding healthcare infrastructure, blood banks, and advanced treatment facilities is further strengthening market development.
Immunoglobulin represents the largest product segment, while albumin is identified as the fastest-growing product category due to its increasing use in critical-care settings. Hospitals are the leading end users, accounting for a significant share of market demand.
Technological improvements in plasma separation, purification, and manufacturing are also creating new opportunities. Centrifugation currently dominates the technology segment, while chromatography is gaining momentum because of its ability to support high-purity plasma products. Overall, increasing healthcare investment, technological advancement, greater awareness of plasma donation, and demand for plasma-derived therapies are expected to drive continued growth in India's plasma fractionation industry.